Alzheimer's Disease
Research and Statistics

Alzheimer's disease is a tragic affliction that can cause a loved one to be unable to remember even the most basic of emotional connections. It can be a tough problem for any family to face, and in this article, we'll discuss some of the basic facts about Alzheimer's in order to give you a more complete understanding of the disease.

Alzheimer's disease is actually a form of dementia, a mental disorder that can cause a person to be able to lose the ability to perform the normal activities in their daily life. Alzheimer's is the most commonly occurring form of dementia, and as many as 4.5 million Americans alone suffer from the disease. At the current time, we don't have any type of cure for the disease, only preventative measures to help to stave off the disease's rate of damage. The disease most commonly occurs in those that are of age sixty or older, and the risk of contracting it increases as a person ages. As a matter of fact, those aged 85 and older face approximately a fifty percent risk of having the disease. That's not to say that the disease is simply caused by aging; scientists are unsure as to why some people become afflicted with the disease while others don't.
[Read More]

More Articles About Alzheimer's Disease

The Basics of Alzheimer's Disease
Alzheimer's disease is a tragic affliction that can cause a loved one to be unable to remember even the most basic of emotional connections. It can be a tough problem for any family to face, and in this article, we'll discuss some of the basic facts about...

African-Americans at an increased Alzheimer's risk
Alzheimer's disease often strikes those old in age and leaves them unable to perform the most basic of human functions. There are many factors that can contribute to Alzheimer's disease, and some groups are more at risk for...

Alzheimer's disease statistics
If you've ever known someone who was afflicted with Alzheimer's disease, you know exactly how devastating the disease can be. It's a terrible problem that can cause a person to lose the abilities to do...

Communicating with someone with Alzheimer's disease
Alzheimer's disease can be a very confusing condition to cope with. Individuals with the disease lose much of their communicative ability and their emotions may run rampant due to the fact that they no longer understand things as easily as...

Coping with Alzheimer's patients
When a person that you love comes down with Alzheimer's disease, it is a life-changing experience. It can be truly heartbreaking to see the person that you love beginning to lose their memories, and as the disease wears on, it becomes more and more troublesome to...

Diagnosing Alzheimer's disease
Alzheimer's disease is a devastating condition that can be very difficult to detect. The only true way that we have of diagnosing the condition is to perform an autopsy and note the presence of amyloid plaque in the brain

Medical advancements in the fight against Alzheimer's
One in three people in the United States of America know someone who has been afflicted with Alzheimer's disease. These people are the ones who can explain exactly how devastating the disease can be to not only...

Risk factors for Alzheimer's disease
One of the most common forms of dementia is a disease named Alzheimer's disease. Commonly occurring in those of an old age, the disease attacks the mind of the individual viciously, causing them to lose...

The history of Alzheimer's disease
Alzheimer's disease is a terrible problem that has been affecting those old in age for centuries. Most of the knowledge that we have about the affliction, we've learned within the past one hundred years.

The stages of Alzheimer's disease
Alzheimer's disease is a degenerative mental disorder that can leave a person confused and frustrated when it comes to simple activities like identifying a family member. The disease can be devastating for both the person afflicted with...

Alzheimer's Disease on the Web

Robbins Umeda LLP Announces Investigation of Medivation, Inc. - MarketWatch (press release)

Robbins Umeda LLP Announces Investigation of Medivation, Inc.
MarketWatch (press release)
Medivation is a biopharmaceutical company with drugs in clinical development to treat diseases including: Alzheimer's disease, Huntington's disease, ...

and more »

Driving With Early Alzheimer's May Be Ill-Advised - U.S. News & World Report

Driving With Early Alzheimer's May Be Ill-Advised
U.S. News & World Report
"Alzheimer's disease affects memory and navigational skills. These impairments may lead to getting lost, which is a life-threatening problem," Hunt said. ...
New Alzheimer's Prevention Efforts, and Non-Drug Treatments, Featured at 25th ...Behavioral Health Central (blog)

all 4 news articles »

Alzheimer's Disease And Dementias - Cortlandt Forum

USA Today

Alzheimer's Disease And Dementias
Cortlandt Forum
... the notion that ginkgo biloba—a popular herbal supplement widely purported to improve memory and cognition—prevents dementia or Alzheimer's disease. ...
Report: Minorities more likely to suffer Alzheimer's diseaseUSA Today
Minorities at Greater Risk for Dementia, Alzheimer's DiseaseFood Consumer
Severe rise in Alzheimer's disease within a generation, new report findsJewish Tribune
WKTV -NewsChannel 9 WSYR -Financial-Planning.com
all 120 news articles »

Alzheimer's Disease Education for Family Members and Friends - WBGH

Alzheimer's Disease Education for Family Members and Friends
WBGH
A series of workshops for Caregivers entitled: Alzheimer's Disease Education for Family Members and Friends. These workshops are offered by The Broome ...
Workshops geared for Alzheimer's caregiversPress & Sun-Bulletin

all 2 news articles »

Glancy Binkow & Goldberg LLP, Representing Investors Who Purchased Medivation ... - MarketWatch (press release)

Glancy Binkow & Goldberg LLP, Representing Investors Who Purchased Medivation ...
MarketWatch (press release)
Medivation is a biopharmaceutical company focused on the development of small molecule drugs for the treatment of Alzheimer's disease, Huntington's disease, ...

and more »

For first time, Seattle team cracks genome of entire family - Seattle Times

Reuters

For first time, Seattle team cracks genome of entire family
Seattle Times
He and his co-workers plan next to sequence genomes from extended families with a high rate of Alzheimer's disease. ISB's co-founder, Leroy Hood, ...
Disease Cause Is Pinpointed With GenomeNew York Times
Human genome decoding is for practical useXinhua

all 183 news articles »

Health Matters: Fighting Alzheimer's With a Positive Attitude - WCTV

Eureka! Science News

Health Matters: Fighting Alzheimer's With a Positive Attitude
WCTV
Finding your purpose in life may cut your risk of developing Alzheimer's Disease two-fold. Doctors collected four years worth of data on nearly 1000 people. ...
New Alzheimer's test offers better opportunities for early detectionEurekAlert (press release)

all 14 news articles »

Pfizer Alzheimer's disease drug fails in study - The Associated Press

MiamiHerald.com

Pfizer Alzheimer's disease drug fails in study
The Associated Press
TRENTON, NJ — A promising Alzheimer's disease drug Pfizer Inc. and a partner are developing failed to work in a late-stage study, a startling disappointment ...
Another potential Alzheimer's medication is a bustLos Angeles Times (blog)
Health Buzz: Alzheimer's Treatment SetbackU.S. News & World Report
Medivation Plunges As Late-Stage Alzheimer's Studies FailWall Street Journal
MarketWatch -RTT News -BusinessWeek
all 685 news articles »

Allon's Phase 1 Trial Broadens Davunetide's Intranasal Safety and Dose Range - MarketWatch (press release)

Allon's Phase 1 Trial Broadens Davunetide's Intranasal Safety and Dose Range
MarketWatch (press release)
The data was presented July 28 and July 30, 2008 to the International Conference on Alzheimer's Disease and Related Disorders (ICAD 2008). ...

and more »

Alzheimer's caregiver shares story on Capitol Hill - Newsday (subscription)

Alzheimer's caregiver shares story on Capitol Hill
Newsday (subscription)
Henley, who was featured in Newsday's series on Alzheimer's disease in October, took her two teenagers to Washington, DC, on Tuesday so they could tell ...

and more »


Google News